Multiply Labs

US · Founded 2016 · CIK 0001690573 · Medtech · Private

Robotic automation systems for pharmaceutical manufacturing and drug compounding

multiplylabs.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$41M
4 Form D · Apr 2023
42 months since last filing
Contracts
—
No federal contracts on record
Patents
39
11 granted · 28 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$2,805,000
Private capital raisedForm D · SEC$2,252,500
Private capital raisedForm D · SEC$25,037,515
Private capital raisedForm D · SEC$11,100,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1104PICCOLO MEDICAL, INC.—$3.3M
1105Everygene, PBC—$7.4M
1106FORCYTE BIOTECHNOLOGIES, INC.—$1.0M
1107Multiply Labs—$41M
1108ALPS DX LLC—$900K
1109EPIEN MEDICAL, INC.—$900K
1110OnPoint Surgical, Inc.—$200K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Jason ArcedianoExecutive Officer
  • Michael DohertyDirector
  • Tiffany KuoDirector
  • Alice MelocchiDirector · Executive Officer
  • Federico PariettiDirector · Executive Officer
  • Shaun RodriguezDirector
  • Krishnan ViswanadhanDirector
  • Joseph WilsonDirector

Patents

USPTO · 11 granted of 39

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.